Drugs / CPI-300
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04808453 | Jun 2021 → Dec 2023 | metastatic neoplasm | Coordination Pharmaceuticals, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CPI-300 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04808453 ↗ |
| Route | Intravenous | “administered via intravenous infusion” NCT04808453 ↗ |